ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,267,028 | -22.6% | 47,154 | +2.7% | 0.00% | -33.3% |
Q2 2023 | $1,638,006 | +50.9% | 45,934 | +7.5% | 0.00% | +50.0% |
Q1 2023 | $1,085,672 | +49.0% | 42,743 | +138.0% | 0.00% | +100.0% |
Q4 2022 | $728,539 | -1.5% | 17,962 | -19.7% | 0.00% | -50.0% |
Q3 2022 | $740,000 | +30.7% | 22,362 | +39.2% | 0.00% | +100.0% |
Q2 2022 | $566,000 | -29.3% | 16,070 | -7.7% | 0.00% | 0.0% |
Q1 2022 | $801,000 | -26.0% | 17,418 | +6.5% | 0.00% | -50.0% |
Q4 2021 | $1,082,000 | +17.4% | 16,349 | +10.8% | 0.00% | 0.0% |
Q3 2021 | $922,000 | -18.3% | 14,759 | +8.4% | 0.00% | 0.0% |
Q2 2021 | $1,128,000 | +34.9% | 13,619 | +8.1% | 0.00% | 0.0% |
Q1 2021 | $836,000 | +141.6% | 12,595 | +179.4% | 0.00% | +100.0% |
Q4 2020 | $346,000 | +81.2% | 4,508 | +1.2% | 0.00% | – |
Q3 2020 | $191,000 | -5.0% | 4,454 | -4.4% | 0.00% | -100.0% |
Q2 2020 | $201,000 | +44.6% | 4,661 | -3.7% | 0.00% | – |
Q1 2020 | $139,000 | -57.1% | 4,841 | -5.2% | 0.00% | -100.0% |
Q4 2019 | $324,000 | +138.2% | 5,108 | +5.8% | 0.00% | – |
Q3 2019 | $136,000 | +10.6% | 4,830 | +4.8% | 0.00% | – |
Q2 2019 | $123,000 | +50.0% | 4,608 | +2.7% | 0.00% | – |
Q1 2019 | $82,000 | +39.0% | 4,486 | -5.6% | 0.00% | – |
Q4 2018 | $59,000 | +742.9% | 4,751 | +375.1% | 0.00% | – |
Q3 2016 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |